[1] Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages [J]. Immunity, 2014, 41(1): 21-35. [2] Pajarinen J, Lin T, Gibon E, et al. Mesenchymal stem cell-macrophage crosstalk and bone healing [J]. Biomaterials, 2019, 196:80-89. [3] Gu Q, Yang H, Shi Q. Macrophages and bone inflammation [J]. J Orthop Translat, 2017, 10:86-93. [4] He XT, Li X, Yin Y, et al. The effects of conditioned media generated by polarized macrophages on the cellular behaviours of bone marrow mesenchymal stem cells [J]. J Cell Mol Med, 2018, 22(2): 1302-1315. [5] Pirraco RP, Reis RL, Marques AP. Effect of monocytes/macrophages on the early osteogenic differentiation of hbmscs [J]. J Tissue Eng Regen Med, 2013, 7(5): 392-400. [6] Vi L, Baht GS, Whetstone H, et al. Macrophages promote osteoblastic differentiation in-vivo: Implications in fracture repair and bone homeostasis [J]. J Bone Miner Res, 2015, 30(6): 1090-1102. [7] Schlundt C, El Khassawna T, Serra A, et al. Macrophages in bone fracture healing: Their essential role in endochondral ossification [J]. Bone, 2018, 106:78-89. [8] Guihard P, Danger Y, Brounais B, et al. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin m signaling [J]. Stem Cells, 2012, 30(4): 762-772. [9] Guihard P, Boutet MA, Brounais-Le Royer B, et al. Oncostatin m, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury [J]. Am J Pathol, 2015, 185(3): 765-775. [10] Ni J, Yuan XM, Yao Q, et al. OSM is overexpressed in knee osteoarthritis and Notch signaling is involved in the effects of OSM on MC3T3-E1 cell proliferation and differentiation [J]. Int J Mol Med, 2015, 35(6): 1755-1760. [11] Lu LY, Loi F, Nathan K, et al. Pro-inflammatory m1 macrophages promote osteogenesis by mesenchymal stem cells via the cox-2-prostaglandin e2 pathway [J]. J Orthop Res, 2017, 35(11): 2378-2385. [12] Ninomiya T, Hosoya A, Hiraga T, et al. Prostaglandin E(2) receptor EP(4)-selective agonist (ONO-4819) increases bone formation by modulating mesenchymal cell differentiation [J]. Eur J Pharmacol, 2011, 650(1): 396-402. [13] Pilbeam C. Prostaglandins and bone [J]. Handb Exp Pharmacol, 2020, 262:157-175. [14] Kanayama S, Kaito T, Kitaguchi K, et al. Ono-1301 enhances in vitro osteoblast differentiation and in vivo bone formation induced by bone morphogenetic protein [J]. Spine (Phila Pa 1976), 2018, 43(11): E616-E624. [15] Horwood NJ. Macrophage polarization and bone formation: A review [J]. Clin Rev Allergy Immunol, 2016, 51(1): 79-86. [16] Chen Z, Wu C, Gu W, et al. Osteogenic differentiation of bone marrow mscs by beta-tricalcium phosphate stimulating macrophages via bmp2 signalling pathway [J]. Biomaterials, 2014, 35(5): 1507-1518. [17] Haversath M, Catelas I, Li X, et al. Pgez and bmp-2 in bone and cartilage metabolism: 2 intertwining pathways [J]. Can J Physiol Pharmacol, 2012, 90(11): 1434-1445. [18] Omar OM, Graneli C, Ekstrom K, et al. The stimulation of an osteogenic response by classical monocyte activation [J]. Biomaterials, 2011, 32(32): 8190-8204. [19] Zhang Y, Bose T, Unger RE, et al. Macrophage type modulates osteogenic differentiation of adipose tissue MSCs [J]. Cell Tissue Res, 2017, 369(2): 273-286. [20] Cho HH, Shin KK, Kim YJ, et al. NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing taz expression [J]. J Cell Physiol, 2010, 223(1): 168-177. [21] Briolay A, Lencel P, Bessueille L, et al. Autocrine stimulation of osteoblast activity by wnt5a in response to tnf-alpha in human mesenchymal stem cells [J]. Biochem Biophys Res Commun, 2013, 430(3): 1072-1077. [22] Zhao L, Huang J, Zhang H, et al. Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1 [J]. Stem Cells, 2011, 29(10): 1601-1610. [23] Zhang H, Hilton MJ, Anolik JH, et al. NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB [J]. J Clin Invest, 2014, 124(7): 3200-3214. [24] Huang H, Zhao N, Xu X, et al. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells [J]. Cell Prolif, 2011, 44(5): 420-427. [25] Zhao B. TNF and bone remodeling [J]. Curr Osteoporos Rep, 2017, 15(3): 126-134. [26] Gong L, Zhao Y, Zhang Y, et al. The macrophage polarization regulates MSC osteoblast differentiation in vitro [J]. Ann Clin Lab Sci, 2016, 46(1): 65-71. [27] Zheng ZW, Chen YH, Wu DY, et al. Development of an accurate and proactive immunomodulatory strategy to improve bone substitute material-mediated osteogenesis and angiogenesis [J]. Theranostics, 2018, 8(19): 5482-5500. [28] Loi F, Cordova LA, Zhang R, et al. The effects of immunomodulation by macrophage subsets on osteogenesis in vitro [J]. Stem Cell Res Ther, 2016, 7:15. [29] Li M, Guo X, Qi W, et al. Macrophage polarization plays roles in bone formation instructed by calcium phosphate ceramics [J]. J Mater Chem B, 2020, 8(9): 1863-1877. [30] Nathan K, Lu LY, Lin T, et al. Precise immunomodulation of the m1 to m2 macrophage transition enhances mesenchymal stem cell osteogenesis and differs by sex [J]. Bone Joint Res, 2019, 8(10): 481-488. |